Resultados de la búsqueda 211-220 of 13191 for Leptospirosis, severe

1. Mayo Clinic Physician Update - June 2023

   Page 1.

2. Hematología - Ensayos clínicos - Mayo Clinic

   All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

3. Enfermedad pulmonar intersticial

   Chronic pulmonary disease. In: Miller's Basics of Anesthesia. 8th ed ... 10, 2024. Portalatin GM, et al. Daptomycin-induced acute eosinophilic pneumonia.

4. Untitled

   Page 1. Page 2.

5. Hematología - Ensayos clínicos - Mayo Clinic

   This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

6. Hematología - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ...

7. Enfermedades alérgicas - Ensayos clínicos - Mayo Clinic

   These immune deficiency diseases are thought to be rare and include: Severe combined immunodeficiency (SCID), leukocyte adhesion deficiency (LAD), X-linked ...

8. Hematología - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

9. Hematología - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic ...